SCIEX BioPhase 8800 Capillary Electrophoresis System with Native Fluorescence Detection (NFD) Module
| Brand | SCIEX |
|---|---|
| Origin | USA |
| Model | BioPhase 8800 + NFD |
| Instrument Type | Capillary Electrophoresis (CE) System |
| Detector | Native Fluorescence Detector (NFD) |
| Sample Format | ANSI/SLAS-compliant 96-well plate |
| CE Modes Supported | CE-SDS, cIEF, CZE |
| Regulatory Compliance | Designed for GLP/GMP environments |
| Linear Dynamic Range | >4 decades |
| Correlation Coefficient (R²) | ≥0.995 |
| Sensitivity | Sub-μg/mL for native protein detection |
Overview
The SCIEX BioPhase™ 8800 Capillary Electrophoresis System with Native Fluorescence Detection (NFD) is an engineered platform for high-throughput, high-fidelity characterization of biopharmaceuticals—including monoclonal antibodies (mAbs), bispecifics, antibody-drug conjugates (ADCs), viral vectors, and mRNA-LNPs. Built on the fundamental principle of electrophoretic mobility separation in fused-silica capillaries under controlled electric fields, the system delivers reproducible resolution of size variants (via CE-SDS), charge isoforms (via capillary isoelectric focusing, cIEF), and structural integrity markers (via CZE). Its eight parallel capillary architecture enables true concurrent analysis—eliminating serial run dependencies while preserving analytical rigor. Unlike conventional single-capillary CE systems, the BioPhase 8800 maintains identical thermal, electrokinetic, and optical conditions across all channels, ensuring inter-channel comparability essential for stability-indicating assays and lot-release testing.
Key Features
- Eight independent capillary channels with synchronized high-voltage power supply and temperature-controlled cartridge housing (±0.1 °C stability)
- Native Fluorescence Detection (NFD) module optimized for label-free detection of intrinsic tryptophan/tyrosine fluorescence—enabling direct quantitation without derivatization or UV-absorbing dyes
- Modular detector interchange: seamless switching between NFD and UV absorbance detection (200–400 nm) without hardware reconfiguration
- Integrated capillary conditioning, rinsing, and priming protocols to minimize carryover (<0.01%) and ensure run-to-run robustness
- ANSI/SLAS-standard 96-well sample tray compatible with third-party liquid handlers (e.g., Tecan, Hamilton, Agilent Bravo) for end-to-end automation
- Real-time voltage and current monitoring per channel with automatic fault detection and pause-on-abnormality logic
Sample Compatibility & Compliance
The BioPhase 8800 supports native, reduced, and non-reduced protein samples ranging from 5 kDa to >200 kDa, including glycosylated species, aggregates, fragments, and post-translationally modified variants. It complies with ICH Q5E comparability guidelines and is routinely deployed in workflows aligned with USP <709>, <1054>, and EP 2.2.46. The system’s software architecture enforces ALCOA+ data integrity principles—supporting role-based access control, full electronic audit trails, and 21 CFR Part 11–compliant electronic signatures. All method parameters, raw data, and processed results are stored in a secure, timestamped, immutable format suitable for regulatory submission packages (e.g., BLA, MAA).
Software & Data Management
SCIEX OS Software v2.1 provides a unified interface for instrument control, method development, and data evaluation. Drag-and-drop sequence building allows rapid construction of multi-assay workflows (e.g., CE-SDS + cIEF in one batch). Peak integration uses adaptive baseline algorithms validated per ASTM E2603–19, with customizable reporting templates exportable to PDF, CSV, or XML for LIMS integration. Batch processing supports automated purity quantitation, molecular weight calibration, pI mapping, and statistical process control (SPC) charting. All raw electropherograms are saved in vendor-neutral .cdf format compliant with ISO/IEC 17025 traceability requirements.
Applications
- Accelerated candidate screening: Simultaneous CE-SDS analysis of 8 mAb candidates for % main peak, fragment %, and aggregate %—reducing cycle time by >60% vs. single-capillary platforms
- cIEF charge variant profiling: High-resolution pI mapping of charge heterogeneity with ≤0.02 pH unit resolution and inter-run RSD <1.5% for migration time
- Process development support: Monitoring glycosylation shifts, deamidation, oxidation, and C-terminal lysine clipping across upstream and downstream unit operations
- Stability studies: Quantitative tracking of degradation pathways under accelerated and real-time storage conditions using native fluorescence signal stability
- Comparability assessments: Statistical equivalence testing (e.g., TOST, ANOVA) across pre- and post-change batches using built-in QC comparison tools
FAQ
What CE modes does the BioPhase 8800 support with the NFD detector?
CE-SDS (reduced and non-reduced), cIEF, and CZE—all with native fluorescence detection capability. UV detection remains available via optional module swap.
Is the system qualified for GMP release testing?
Yes. The platform includes IQ/OQ documentation templates, validation protocols aligned with ASTM E2500–13, and software features meeting FDA 21 CFR Part 11 and EU Annex 11 requirements.
Can the NFD module detect low-abundance host cell proteins (HCPs)?
NFD sensitivity is optimized for therapeutic proteins (LOD ~0.1–0.5 µg/mL); for HCP detection, orthogonal methods (e.g., ELISA or LC-MS) are recommended per ICH Q5A(R2).
How is capillary lifetime managed across eight channels?
Each capillary is individually monitored for current decay and pressure response; predictive maintenance alerts trigger at 85% of nominal lifetime, with average capillary longevity exceeding 300 runs under standard mAb CE-SDS conditions.
Does the system support method transfer from legacy single-capillary CE platforms?
Yes. SCIEX provides method translation guides and empirical correlation tools to align migration times, resolution, and quantitation accuracy between BioPhase 8800 and prior-generation CE instruments (e.g., Beckman PA 800+, Agilent CE).
